(Q38149163)

29 August 2017

title

Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients (English)

1 reference

29 August 2017

0 references

Federico Pea

1

0 references

language of work or name

1 reference

4 October 2013

1 reference

Expert Review of Anti-infective Therapy

29 August 2017

published in

1 reference

29 August 2017

volume

11

1 reference

29 August 2017

issue

10

1 reference

29 August 2017

page(s)

989-997

1 reference

Fungal sepsis: optimizing antifungal therapy in the critical care setting

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Septic shock attributed to Candida infection: importance of empiric therapy and source control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Invasive fungal infections in the intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Candida spp. bloodstream infection: influence of antifungal treatment on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Anidulafungin versus fluconazole for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

21 January 2018

Fever management in SAH.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Continuous low dose diclofenac sodium infusion to control fever in neurosurgical critical care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Bench-to-bedside review: Candida infections in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Risk factors for fluconazole-resistant candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

The pathophysiology and treatment of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Effects of echinocandins on cytokine/chemokine production by human monocytes activated by infection with Candida glabrata or by lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

A drug-sensitive genetic network masks fungi from the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Immunocompromised hosts: immunopharmacology of modern antifungals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

The echinocandins: three useful choices or three too many?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Echinocandin antifungal drugs in fungal infections: a comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Pharmacokinetics of caspofungin in two patients with burn injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Pharmacokinetics of liposomal amphotericin B in pleural fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Candida peritonitis: an update on the latest research and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Infective endocarditis in the U.S., 1998-2009: a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Antifungal combinations against simulated Candida albicans endocardial vegetations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Ocular penetration of caspofungin in a rabbit uveitis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Intraocular penetration of intravenous micafungin in inflamed human eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady state

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Voriconazole in the treatment of fungal eye infections: a review of current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Candida urinary tract infections--diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Effect of diabetes mellitus on the clinical and microbiological features of hospitalized elderly patients with acute pyelonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836058

10.1586/14787210.2013.836058

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference